LABATE, Angelo
 Distribuzione geografica
Continente #
EU - Europa 3.752
NA - Nord America 3.553
AS - Asia 2.328
SA - Sud America 786
Continente sconosciuto - Info sul continente non disponibili 125
AF - Africa 68
OC - Oceania 9
Totale 10.621
Nazione #
US - Stati Uniti d'America 3.377
RU - Federazione Russa 2.203
SG - Singapore 952
BR - Brasile 647
IE - Irlanda 518
HK - Hong Kong 415
CN - Cina 397
IT - Italia 365
SE - Svezia 250
VN - Vietnam 174
BD - Bangladesh 95
DE - Germania 85
CA - Canada 70
GB - Regno Unito 66
FR - Francia 60
IN - India 56
AR - Argentina 49
MX - Messico 45
AT - Austria 42
TR - Turchia 27
FI - Finlandia 24
ID - Indonesia 24
IQ - Iraq 24
CO - Colombia 23
EC - Ecuador 23
PK - Pakistan 22
NL - Olanda 21
PL - Polonia 21
ES - Italia 18
JP - Giappone 18
ZA - Sudafrica 18
UA - Ucraina 16
DZ - Algeria 15
MY - Malesia 14
DK - Danimarca 13
UZ - Uzbekistan 13
IL - Israele 11
MA - Marocco 11
TN - Tunisia 10
VE - Venezuela 10
JM - Giamaica 9
NI - Nicaragua 9
PH - Filippine 9
PY - Paraguay 9
CL - Cile 8
GT - Guatemala 8
CZ - Repubblica Ceca 7
HN - Honduras 7
KZ - Kazakistan 7
AZ - Azerbaigian 6
BG - Bulgaria 6
BO - Bolivia 6
KG - Kirghizistan 6
LV - Lettonia 6
PA - Panama 6
PE - Perù 6
TT - Trinidad e Tobago 6
AM - Armenia 5
AU - Australia 5
CR - Costa Rica 5
JO - Giordania 5
KR - Corea 5
LT - Lituania 5
SY - Repubblica araba siriana 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
BY - Bielorussia 4
IR - Iran 4
KE - Kenya 4
NZ - Nuova Zelanda 4
OM - Oman 4
RS - Serbia 4
TH - Thailandia 4
TW - Taiwan 4
EG - Egitto 3
PS - Palestinian Territory 3
SA - Arabia Saudita 3
AL - Albania 2
BB - Barbados 2
BE - Belgio 2
CI - Costa d'Avorio 2
CY - Cipro 2
GR - Grecia 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
NO - Norvegia 2
NP - Nepal 2
PR - Porto Rico 2
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CG - Congo 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
KH - Cambogia 1
KW - Kuwait 1
Totale 10.483
Città #
Moscow 683
Dublin 517
Ashburn 466
Hong Kong 412
Singapore 384
San Jose 288
Council Bluffs 256
Nyköping 230
Dallas 191
Princeton 184
Medford 165
Chandler 136
The Dalles 105
Messina 104
Beijing 98
Los Angeles 95
Santa Clara 66
São Paulo 63
New York 52
Ho Chi Minh City 51
Hanoi 42
Nuremberg 36
Munich 31
Phoenix 31
Buffalo 26
Vienna 24
Tianjin 23
Milan 22
Brooklyn 21
Houston 21
Redondo Beach 21
Brasília 20
Chicago 20
Orem 20
Shanghai 20
Lauterbourg 19
Mexico City 19
Bari 18
Tokyo 18
Denver 17
Rio de Janeiro 17
Chennai 16
Guangzhou 15
Warsaw 15
Atlanta 14
Poplar 14
Toronto 14
Palermo 13
Shenzhen 13
Belo Horizonte 12
Seattle 12
Amsterdam 11
Boston 11
Catania 11
Dhaka 11
Florence 11
Frankfurt am Main 11
Rome 11
San Francisco 11
Stockholm 11
Tashkent 11
Columbus 10
Montreal 10
Brøndby 9
Johannesburg 9
Lappeenranta 9
Mumbai 9
Naples 9
Porto Alegre 9
Settimo Torinese 9
Turku 9
Guarulhos 8
Guayaquil 8
Haiphong 8
Managua 8
Miami 8
Querétaro 8
Salvador 8
Asunción 7
Da Nang 7
Kuala Lumpur 7
London 7
Ankara 6
Bishkek 6
Bogotá 6
Campinas 6
Jacksonville 6
Karachi 6
Kingston 6
Manchester 6
Prague 6
Quito 6
Riga 6
Sorocaba 6
Baghdad 5
Bagheria 5
Baku 5
Boardman 5
Casablanca 5
Catanzaro 5
Totale 5.558
Nome #
CPAP therapy improved sleep and reduced seizures in a young, obese epileptic woman with OSA 199
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) 163
A case of frontal lobe seizures with ‘dancing-like’ semiology 158
The real-world effectiveness of intravenous brivaracetam as a second-line treatment in status epilepticus 154
A retrospective multicentric study on the effectiveness of intravenous brivaracetam in seizure clusters: Data from the Italian experience 145
Management of status epilepticus in patients with liver or kidney disease: a narrative review 133
Human expressive movements: The boundary between health and disease from a contaminated perspective 132
Genetics of reflex seizures and epilepsies in humans and animals 127
A systems-level analysis highlights microglial activation as a modifying factor in common epilepsies 122
AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives 120
MR-Guided Focused Ultrasound for Refractory Epilepsy: Where Are We Now? 119
A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide 117
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 114
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 113
A Functional Genetic Variation of the 5-HTR2A Receptor Affects Age at Onset in Patients with Temporal Lobe Epilepsy 113
Insight into epileptic and physiological déjà vu: from a multicentric cohort study 111
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST) 110
White matter abnormalities across different epilepsy syndromes in adults: an ENIGMA-Epilepsy study 110
Advanced MRI Morphologic Study Shows No Atrophy in Healthy Individuals with Hippocampal Hyperintensity 109
Epilepsy Study Group of the Italian Neurological Society. Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis. 109
SLEEP HYPERMOTOR EPILEPSY VS NREM PARASOMNIAS: A CHALLENGING CASE REPORT 108
Binaural Beats Reduce Postoperative Morphine Consumption in Older adults After Total Knee Replacement Surgery 107
Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy 107
Advanced morphological neuroimaging study in lateral temporal lobe epilepsy: A multicentric study 105
Spectrum of epilepsy with eyelid myoclonia: Delineation of disease subtypes from a large multicenter study 102
A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy 102
Lacosamide in patients with temporal lobe epilepsy: An observational multicentric open-label study 102
Epilepsy associated with Leukoaraiosis mainly affects temporal lobe: a casual or causal relationship? 100
Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST) (CNS Drugs, (2021), 35, 12, (1289-1301), 10.1007/s40263-021-00856-3) 100
3-T magnetic resonance imaging simultaneous automated multimodal approach improves detection of ambiguous visual hippocampal sclerosis 99
A novel mutation in the notch3 gene in an Italian family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: genetic and MRI spectroscopic analyses 98
Sex-based electroclinical differences and prognostic factors in epilepsy with eyelid myoclonia 96
Adolescents with Neuropsychiatric Disorders during the COVID-19 Pandemic: Focus on Emotional Well-Being and Parental Stress. 96
Detection of hippocampal atrophy in patients with temporal lobe epilepsy: a 3-Tesla MRI shape 95
Diagnostic Biomarkers of Epilepsy 94
Epilepsy beyond seizures: embracing a holistic perspective. Proceedings of the 2nd meeting (Episicily) of the epilepsy study group of the Italian Society of neurology 94
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 93
A familial t(4;8) translocation segregates with epilepsy and migraine with aura 93
Event-based modeling in temporal lobe epilepsy demonstrates progressive atrophy from cross-sectional data 91
A Loss-of-Function HCN4 Mutation Associated With Familial Benign Myoclonic Epilepsy in Infancy Causes Increased Neuronal Excitability 91
Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis 90
Failure to confirm association of a polymorphism in KCNMB4 gene with mesial temporal lobe epilepsy 89
Perampanel as first add-on choice on the treatment of mesial temporal lobe epilepsy: an observational real-life study 89
Brand-to-generic levetiracetam switching: a 4-year prospective observational real-life study 89
Acute bulbar palsy without ophtalmoplegia associated with anti-GD3 IgM antibodies 88
Late drug-resistance in mild MTLE: Can it be influenced by preexisting white matter alterations? 88
Deep Learning Representation from Electroencephalography of Early-Stage Creutzfeldt-Jakob Disease and Features for Differentiation from Rapidly Progressive Dementia 87
A brainstem hypermetabolism in a patient with essential palatal tremor: A simultaneous 18F-FDG-PET/3 T-MRI study 87
Epilepsy and sleep disorders improve in adolescents and adults with Angelman syndrome: A multicenter study on 46 patients 87
Myoclonus: Differential diagnosis and current management 85
The ENIGMA-Epilepsy working group: Mapping disease from large data sets 85
Corticobulbar activity in healthy humans and Parkinson’s disease: a study protocol for a novel biomarker of motivational arousal 84
Generalized versus partial reflex seizures: a review. 84
Autosomal dominant lateral temporal epilepsy (ADLTE): absence of chromosomal rearrangements in LGI1 gene 84
Profile of brivaracetam and its potential in the treatment of epilepsy 84
Lamotrigine positively affects the development of psychiatric comorbidity in epileptic animals, while psychiatric comorbidity aggravates seizures 84
Efficacy and safety of branded vs generic lacosamide in epilepsy: a retrospective real-world study 83
Progressive myoclonus epilepsies—Residual unsolved cases have marked genetic heterogeneity including dolichol-dependent protein glycosylation pathway genes 81
Epilepsy and Immune System: A Tour Around the Current Literature 81
A puzzling case without solution: isolated late-onset epileptic seizure 81
A novel mutation in the Notch3 gene in an Italian family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: genetic and magnetic resonance spectroscopic findings 80
Topographic divergence of atypical cortical asymmetry and atrophy patterns in temporal lobe epilepsy 79
Structural network alterations in focal and generalized epilepsy follow axes of epilepsy risk gene expression: an enigma study. 78
Network-based atrophy modeling in the common epilepsies: A worldwide ENIGMA study 76
Family history and frontal lobe seizures predict long-term remission in newly diagnosed cryptogenic focal epilepsy 76
Looking for indicative magnetic resonance imaging signs of hippocampal developmental abnormalities in patients with mesial temporal lobe epilepsy and healthy controls 75
Psychiatric and Behavioural Side Effects Associated With Perampanel in Patients With Temporal Lobe Epilepsy. A Real-World Experience 73
Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice 73
Circulating microRNAs as Potential Novel Diagnostic Biomarkers to predict Drug Resistance in Temporal Lobe Epilepsy: a Pilot Study 73
Interpretable surface-based detection of focal cortical dysplasias: a MELD study. 71
Exercise-induced rhabdomyolysis as unusual manifestation of GLUT-1 Deficiency Syndrome 69
Enlarging the clinical spectrum of chorea-acanthocytosis 68
Genome-wide identification and phenotypic characterization of seizure-associated copy number variations in 741,075 individuals 65
Management of psychogenic non-epileptic seizures: a multidisciplinary approach 63
GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture 58
Utility of raw electroencephalography monitoring for estimating level of sedation in the perioperative setting 55
The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy 54
The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a “real world” context: focus on temporal lobe epilepsy 52
Determinants of health-related quality of life in pharmacoresistant epilepsy: Results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments 51
Atlas of lesion locations and postsurgical seizure freedom in focal cortical dysplasia: A MELD study 50
The mystery of unexplained traumatic sudden falls. A clinical case that adds a new feasible cause 50
Validation Study of Italian Version of Inventory for Déjà Vu Experiences Assessment (I-IDEA): A Screening Tool to Detect Déjà Vu Phenomenon in Italian Healthy Individuals 50
Psychiatric Assessment in Patients with Mild Temporal Lobe Epilepsy 49
The efficacy of switching intravenous to oral brivaracetam following status epilepticus: A real-world, multicenter Sicilian study 48
Relationship between genetic variant in pre-microRNA-146a and genetic predisposition to temporal lobe epilepsy: A case-control study 48
ApoE epsilon4 allele and disease duration affect verbal learning in mild temporal lobe epilepsy 48
Sleep effects in drug-resistant epileptic patients taking perampanel: an observational study 47
Benign mesial temporal lobe epilepsy 46
Juvenile Huntington's disease presenting as progressive myoclonic epilepsy 46
Usefulness of rectal biopsy for the diagnosis of Kufs disease: a controlled study and review of the literature 44
Kufs disease due to mutation of CLN6: clinical, pathological and molecular genetic features 44
Long-term outcome of mild mesial temporal lobe epilepsy 44
Temporal lobe epilepsy as a unique manifestation of multiple sclerosis 43
Anti-N-methyl-D-aspartate-glutamic-receptor encephalitis presenting as paroxysmal exercise-induced foot weakness 41
Amygdala dysplasia with temporal lobe epilepsy and obsessive-compulsive disorder: An fMRI/EEG study 41
Artificial intelligence for classification of temporal lobe epilepsy with ROI-level MRI data: A worldwide ENIGMA-Epilepsy study 41
Predictive factors of Status Epilepticus and its recurrence in patients with adult–onset seizures: A multicenter, long follow–up cohort study 40
Mutations in PRRT2 result in familial infantile seizures with heterogeneous phenotypes including febrile convulsions and probable SUDEP 40
Typical childhood absence seizures are associated with thalamic activation 40
Positivity to p-ANCA in patients with status epilepticus 39
Totale 8.489
Categoria #
all - tutte 40.180
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.180


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022363 0 0 0 3 0 0 1 1 2 5 2 349
2022/20231.145 193 103 54 7 12 65 51 21 604 4 29 2
2023/2024333 17 46 35 112 18 20 4 4 0 45 8 24
2024/20251.973 30 31 102 46 148 109 128 164 427 207 207 374
2025/20265.753 303 310 356 471 498 1.143 676 636 629 361 177 193
2026/20271.032 192 330 436 74 0 0 0 0 0 0 0 0
Totale 10.621